Lifeboat Foundation

To the general public, lasers heat objects. And generally, that would be correct.

But lasers also show promise to do quite the opposite — to cool materials. Lasers that can cool materials could revolutionize fields ranging from bio-imaging to quantum communication.

In 2015, University of Washington researchers announced that they can use a laser to cool water and other liquids below room temperature. Now that same team has used a similar approach to refrigerate something quite different: a solid semiconductor. As the team shows in a paper published today (June 23, 2020) in Nature Communications, they could use an infrared laser to cool the solid semiconductor by at least 20 degrees C, or 36 F, below room temperature.

Fantastic article on Dr Yuancheng Ryan Lu’s age reversal experiment.

“ It suggests that it is entirely possible to reverse aging in cells with the use of a molecular mechanism already present in the cells. And so, scientists are now off to the races in the hopes of finding this cellular mechanism, and ways to activate this correction system in living beings…”

In 2006, Dr. Shinya Yamanaka, a Japanese stem cell researcher, published his paper on induced pluripotent stem cells, and it changed the medical world. Dr. Yamanaka had found a way to convert a mature skin cell into a stem cell by injecting just a few genes. And for this, Dr. Yamanaka received the Nobel Prize in Physiology or Medicine in 2012, sharing it with another Sir John B. Gurdon, who found another method of inducing pluripotency.

Continue reading “Stem Cells: The Key to Reversing Biological Age” »

Not even the lawyers will be spared.

In the summer of 2015, Stanford-bound high school grad Josh Browder spent his nights coding and developing an automated program that would help people contest parking tickets. The native Londoner had recently gotten his driver’s license, and had himself assembled a respectable collection of fines, some of which he felt were unjustly rewarded.

About three weeks later, Browder already had a product called DoNotPay which he shared with his friends. A blogger from Reddit picked up on it, and almost overnight, DoNotPay went from 10 people using it to 50,000 users.

Continue reading “Stanford Grad Who Created The World’s First ‘Robot Lawyer’ Raises $12 Million In Series A” »

Click on photo to start video.

This shape-shifting material is blowing our minds.

NASA scientists decided to explore whether — hypothetically — there are ocean planets in the Milky Way galaxy that are similar to the watery solar system moons Europa and Enceladus.

Laser labs that detect ripples in space-time may have witnessed a new class of cosmic object.

Automated tabletop machine could accelerate the development of novel drugs to treat cancer and other diseases.

Many proteins are useful as drugs for disorders such as diabetes, cancer, and arthritis. Synthesizing artificial versions of these proteins is a time-consuming process that requires genetically engineering microbes or other cells to produce the desired protein.

MIT chemists have devised a protocol to dramatically reduce the amount of time required to generate synthetic proteins. Their tabletop automated flow synthesis machine can string together hundreds of amino acids, the building blocks of proteins, within hours. The researchers believe their new technology could speed up the manufacturing of on-demand therapies and the development of new drugs, and allow scientists to design artificial proteins by incorporating amino acids that don’t exist in cells.

Do you agree Eric Klien?

Tesla’s EBITDA will be almost twice as high as Uber’s in 2025, Morgan Stanley projected in a note to clients.

“We knew from Chinese publications that patients with a severe and even fatal course of the disease are characterized by a so-called cytokine storm,” Neubauer says. “During a cytokine storm, the body is flooded with substances that stimulate the immune system.” This overreaction of the body’s own defense system damages the tissue—making it all the easier for the invading virus to spread.

Neubauer suspected that the patient might respond to ruxolitinib, a drug originally used in cancer treatment. It inhibits enzymes in the body involved in excessive inflammatory reactions. “We suggested to our colleagues who were treating the patients that the cancer drug might be able to prevent the life-threatening effects brought on by the inflammatory damage to lung tissue,” Neubauer says.

Although the spreading SARS-CoV-2 coronavirus usually causes only mild respiratory symptoms, the COVID-19 disease progresses so severely in around five percent of those affected that acute respiratory distress can occur. “The mortality rate in these cases is high,” says Dr. Thomas Wiesmann, who attended the patient along with the intensive care team in the Department of Anesthesia and Intensive Care at Marburg University Hospital.